INTEGRA NEUROSCIENCES LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  -2.7%

  £21,857,000 → £21,267,000

• Cash

  -53.9%

  £14,541,000 → £6,704,000

• Net assets

  -50.3%

  £17,903,000 → £8,905,000

• Employees

  +5.3%

  38 → 40

• Operating profit

  +46%

  £576,000 → £841,000

• Profit before tax

  +45.5%

  £578,000 → £841,000

• Wages

  +5.4%

  £3,298,000 → £3,475,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. INTEGRA NEUROSCIENCES LIMITED 2003-03-12 → present
2. SPEMBLY MEDICAL LIMITED 1987-04-08 → 2003-03-12
3. STOCKCO (NO.96) LIMITED 1986-12-31 → 1987-04-08

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

BDO LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“On the basis of their assessment of the Company's financial position and resources, the directors believe that the Company is well placed to manage its business risks. In making this assessment management have prepared cashflow forecasts to December 2026 including severe yet plausible downside scenarios and are comfortable that the company has sufficient liquid resources and will continue to be supported by the wider group as a distributor. Therefore the directors have concluded that there is no material uncertainty with respect to the Company's going concern and that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the annual financial statements.”

Group structure

1. INTEGRA NEUROSCIENCES LIMITED · parent
   1. Spembly Cryosurgery Limited 100% · England and Wales · dormant

Significant events

• “In 2024 the group of which the company is a part, announced a voluntary recall of our Pattie products.”
• “In 2023 the group of which the company is a part, announced a voluntary recall of our Surgimed product and production stopped at the Group's Boston facility.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

8

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.